UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT~~Pursuant TOto ~~SECTION~~Section 13 ORor 15(d) ~~OF THE~~

~~SECURITIES~~of ~~EXCHANGE~~the ~~ACT~~Securities OFExchange Act of 1934

Date of Report (~~Date~~date of earliest event reported): ~~March~~July 118, 2022

AZAR INTERNATIONAL CORP. (Exact ~~name~~Name of ~~registrant~~Registrant as ~~specified~~Specified in its ~~charter~~Charter)

Nevada	333-234137	98-1448750
(State or other jurisdiction of Incorporation or organization)	Registration No.	(I.R.S. Employer Identification Number)
(State of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

Carretera Turistica, Luperon, 12th km, No. 7, Grand Parada, Puerto Plata, Dominican Republic (Address of principal executive offices) (Zip Code)

(Address of principal executive offices and zip code)

(829) 947-5251

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered N/A N/A N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Item~~Securities ~~4.01~~registered ~~Changes~~under inSection ~~Registrant’s~~12(g) ~~Certifying~~of ~~Accountant.~~the Exchange Act: None

~~(a)~~Securities ~~Resignation~~registered ofpursuant ~~Previous~~to ~~Independent~~Section ~~Registered~~12(b) ~~Public~~of ~~Accounting~~the ~~Firm.~~Act: None

OnTitle ~~March~~of ~~11,~~each ~~2022,~~class weTrading ~~dismissed Zia Masood Kiani & Co.~~ Symbol(~~“ZMK”~~s) asName ~~our company’s independent principal accountant to audit the Company’s financial statements. The decision to change accountants was approved by our board~~ of ~~directors.~~each ~~Our~~exchange ~~company~~on ~~does~~which ~~not~~registered ~~have~~N/A aN/A ~~standing Audit Committee.~~N/A

~~Our~~Item ~~company’s~~5.01 ~~independent~~Changes ~~principal~~in ~~accountant’s~~Control ~~report on the financial statements for the year ended August 31, 2021 and 2020 did not contain an adverse opinion or a disclaimer~~ of opinion, and was not qualified or modified as to uncertainty, audit scope, or accounting principles, with the exception that the reports dated October 5, 2020 and November 18, 2021 contained the following explanatory paragraph: “The accompanying financial statements have been prepared assuming that the Company will continue as a going concern”Registrant.

~~During~~On ~~our~~July ~~company’s~~8, ~~two~~2022, ~~most~~as ~~recent~~a ~~fiscal~~result ~~year~~of ~~and~~a upprivate totransactions, ~~the~~3,000,000 ~~date~~shares of ~~dismissal~~common ~~of ZMK~~stock, ~~there~~$0.001 ~~were:~~par ~~(i)~~value noper ~~disagreements~~share ~~with~~(the ~~ZMK~~“Shares”) onof ~~any~~AZAR ~~matter~~INTERNATIONAL ofCORP., ~~accounting~~a ~~principles~~Nevada orcorporation ~~practices~~(the “Company”), ~~financial~~were ~~statement~~transferred ~~disclosure~~from orHilario ~~auditing~~Lopez ~~scope~~Vargas orto ~~procedure~~Yang, ~~which~~Lixue ~~disagreements~~(the “Purchaser”). As a result, ifthe ~~not~~Purchaser ~~resolved~~became toholders of approximately 77% of the ~~satisfaction~~voting rights of ~~ZMK,~~the ~~would~~issued ~~have~~and ~~caused~~outstanding itshare tocapital ~~make~~of ~~reference~~the toCompany and became the ~~subject~~controlling ~~matter~~shareholder. ofThe consideration paid for the ~~disagreements~~Shares inwas ~~its~~$350,000. ~~reports~~The onsource of the ~~consolidated~~cash ~~financial~~consideration ~~statements~~for the Shares was personal funds of the ~~Company;~~Purchaser. ~~and~~In ~~(ii)~~connection nowith ~~reportable~~the ~~events~~transaction, asHilario ~~described~~Lopez inVargas ~~Item~~released ~~304(a)(1)(v)~~the ofCompany ~~Regulation~~from ~~S-K~~all debts owed to him.

WeOther ~~have~~than ~~provided~~as ~~ZMK~~described ~~with~~below, athere ~~copy~~are ofno ~~this~~arrangements ~~Form~~or ~~8-K~~understandings ~~prior~~among toboth ~~its filing with~~ the ~~U.S.~~former ~~Securities~~ and ~~Exchange~~new ~~Commission~~control ~~(“SEC”)~~persons and ~~requested~~their ~~ZMK~~associates towith ~~furnish~~respect to ~~our~~the ~~company~~election aof ~~letter~~directors ~~addressed~~of to the ~~SEC~~Company ~~stating~~or ~~that~~other itmatters. ~~agrees~~The ~~with~~information ~~the~~set ~~statements~~forth ~~made~~in ~~above~~Item 5.02 ~~A copy~~ of ~~ZMK’s~~this ~~letter~~Form 8-K is ~~attached~~incorporated asby ~~Exhibit~~reference ~~16.1~~into to this ~~Form~~Item ~~8-K~~5.01.

~~(b)~~Item ~~Engagement~~5.02 Departure of ~~New~~Directors ~~Independent~~or ~~Registered~~Certain ~~Public~~Officers; ~~Accounting~~Election ~~Firm~~of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On ~~March~~July 118, 2022, wethe ~~engaged~~existing ~~MICHAEL~~director ~~GILLESPIE~~and &officer ~~ASSOCIATES~~resigned immediately. Accordingly, ~~PLLC~~Hilario Lopez Vargas, serving as ~~our~~a ~~new~~director ~~independent~~and ~~registered~~an ~~accounting~~officer, ~~firm~~ceased ~~with~~to be the ~~approval~~Company’s Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director. At the effective date of ~~our~~the ~~board~~transfer, Yang, Lixue consented to act as the new Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director of ~~directors.~~the Company,

~~During~~Mr. ~~the~~Yang, ~~two~~Lixue, ~~most~~CEO, ~~recent~~CFO, ~~fiscal~~and ~~years~~Director, ~~and~~39, ~~through~~Graduated ~~the~~from ~~date~~University of ~~engagement~~Science and Technology Beijing in 2006, wemajoring ~~have~~in ~~not~~marketing ~~consulted~~and ~~with~~management. ~~MICHAEL~~He ~~GILLESPIE~~is &the ~~ASSOCIATES~~president, ~~PLLC~~Chief ~~regarding~~Executive ~~either:~~Officer and chairman of the Board of Directors of the Company.

1Mr. ~~The~~Yang ~~application~~was the CEO of ~~accounting~~Shandong ~~principles~~Zhongying toNetwork ~~any~~Technology ~~specified~~Co. ~~transaction~~Ltd, ~~either~~from ~~completed~~2012 orto ~~proposed,~~2015. orHe was the ~~type~~CEO of ~~audit~~Zhejiang ~~opinion~~Luo ~~that~~Fang ~~might~~Technology beCo., ~~rendered on our financial statements~~Ltd, ~~and~~from ~~neither~~2015 ato ~~written~~2017. ~~report~~After ~~was~~that, ~~provided~~he tofounded usa ~~nor~~company ~~oral~~called ~~advice~~Qingdao ~~was~~Qingliyuan ~~provided~~Biotechnology ~~that~~Co., ~~MICHAEL~~Ltd ~~GILLESPIE~~in ~~& ASSOCIATES~~2017, ~~PLLC~~up ~~concluded~~to ~~was~~present. anHe ~~important~~was ~~factor~~also ~~considered~~the byfounder usand inchairman ~~reaching~~of aYizhixin ~~decision~~Co., ~~as to the accounting~~Ltd, ~~auditing~~from or2018 ~~financial~~to ~~reporting~~present. ~~issue; or~~

2. Any matter that was either subject of disagreement or event, as defined in Item 304(a)(1)(iv)(A) of Regulation S-K and the related instruction to Item 304 of Regulation S-K, or a reportable event, as that term is explained in Item 304(a)(1)(iv)(A) of Regulation S-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

16.1	Letter from Zia Masood Kiani & Co.
10.1		STOCK PURCHASE AGREEMENT, dated July 8, 2022, by and between Hilario Lopez Vargas and Yang, Lixue
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)
99.1		DIRECTORS RESOLUTIONS, dated July 8, 2022.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

~~AZAR~~July ~~INTERNATIONAL CORP. /s/ Hilario Lopez Vargas Hilario Lopez Vargas Chief Executive Officer Date: March~~ 11, 2022

AZAR INTERNATIONAL CORP.

	/s/ Yang, Lixue
By:	YANG, LIXUE
Title:	CEO

Filing Compare · QLY Biotech Group Corp.